Is This Sizzling Dividend Stock a Buy?
Fears about the health of the U.S. economy have led the S&P 500 index 13% lower so far in 2022.
However, some stocks have tremendously outperformed the index. Up 24% year to date, health insurer Cigna (NYSE: CI) has crushed the S&P 500. Is the stock still a buy or has it run up too far, too fast? Let's take a look at the company's fundamentals and valuation to decide.
Earlier this month, Cigna released its financial results for the second quarter ended June 30. Once again, the company topped the analyst consensus estimates for revenue and non-GAAP (adjusted) diluted earnings per share (EPS).
Source Fool.com
